NBC SECURITIES, INC.
Broker-DealerPosition in AKTS — Aktis Oncology, Inc.
CIK 791540
BIRMINGHAM, AL
Position in AKTS
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$172,688
New position
Shares Held
5,358
first reported quarter
Ownership
0.010%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#3
of 10 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026NBC SECURITIES, INC. holds $5,111,855 across 54 Biotechnology names. AKTS ranks #12 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
10,414 | $815,103 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
1,623 | $397,261 | |
| 3 | TSHA |
Taysha Gene Therapies, Inc.
|
55,022 | $374,699 | |
| 4 | INBX |
Inhibrx Biosciences, Inc.
|
3,900 | $369,525 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
2,545 | $311,966 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
2,591 | $303,328 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
435 | $271,239 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
4,479 | $246,345 |
All Filings in AKTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $172,688 | 5,358 | Shares | Sole | 2026-07-21 | |
| No filing history on record for this holder in this stock. | ||||||